Dispensing: Pharmacy Information Systems

  • Sandra H. Mitchell
  • Michael A. Veltri
  • George R. Kim
Part of the Health Informatics book series (HI)


Medication delivery and administration, especially in inpatient settings, are complex and error prone processes. The multiple dimensions and levels of detail to which specific drugs must be specified, the numbers of handoffs and transformations (calculation and conversion) of patient and drug specific data that must occur, and the manipulations (compounding, dilution, and dose preparation), make medication delivery highly vulnerable to variation and errors of commission and omission.

In pediatrics, these complexities (and the potential for error and harm) are further magnified by the special needs of children: universal weight-based or body surface area-based dosing, the need for alternative drug forms and routes of administration, differential pharmacokinetics in developing physiologic systems and the long-term and cumulative effects of drugs. To improve pediatric medication safety, automation, and information technology (IT) are used to standardize and streamline the drug and associated data processes.


Medication Delivery Clinical Decision Support Clinical Decision Support System Computerize Physician Order Entry Pharmacy Staff 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rich, Darryl S. New JCAHO medication management standards for 2004. Am J Health-Syst Pharm. 2004;61:1349–1359.PubMedGoogle Scholar
  2. 2.
    Chaffee BW, Bonasso J. Strategies for pharmacy integration and pharmacy information system interfaces, Part 1: history and pharmacy integration options. Am J Health Syst Pharm. 2004;61(5):502–506.PubMedGoogle Scholar
  3. 3.
    Chaffee BW, Bonasso J. Strategies for pharmacy integration and pharmacy information system interfaces, Part 2: scope of work and technical aspects of interfaces. Am J Health Syst Pharm. 2004;61(5):506–514.PubMedGoogle Scholar
  4. 4.
    Chaffee BW, Townsend KA, Benner T, de Leon RF. Pharmacy database for tracking drug costs and utilization. Am J Health Syst Pharm. 2000;57(7):669–676.PubMedGoogle Scholar
  5. 5.
    Osheroff JA, Teich JM, Middleton BF, Steen, EB, Wright A, Detmer DE. A Roadmap for National Action on Clinical Decision Support. American Medical Informatics Association; 2006. Available at: Accessed December 21, 2008.
  6. 6.
    Liem RI, Higman MA, Chen AR, Arceci RJ. Misinterpretation of a Calvert-derived formula leading to carboplatin overdose in two children. J Pediatr Hematol Oncol. 2003;25(10):818–821.PubMedCrossRefGoogle Scholar
  7. 7.
    van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2005;13(2):138–147. Available at: http://www. Accessed December 21, 2008.Google Scholar
  8. 8.
    Kuperman GJ, Gandhi TK, Bates DW. Effective drug-allergy checking: methodological and operational issues. J Biomed Inform. 2003;36(1–2):70–79.PubMedCrossRefGoogle Scholar
  9. 9.
    Pham PA. Drug-drug interaction programs in clinical practice. Clin Pharmacol Ther. 2008;83(3):396–398.PubMedCrossRefGoogle Scholar
  10. 10.
    Alkema GE, Wilber KH, Simmons WJ, Enguidanos SM, Frey D. Prevalence of potential medication problems among dually eligible older adults in Medicaid waiver services. Ann Pharmacother. 2007;41(12):1971–1978.PubMedCrossRefGoogle Scholar
  11. 11.
    Koren G, Schechter T. Cancer chemotherapy in young children: challenges and solutions. Pediatr Blood Cancer. 2007;49(7 Suppl):1091–1092.PubMedCrossRefGoogle Scholar
  12. 12.
    Green DM, Grigoriev YA, Nan B, et al. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. J Clin Oncol. 2001;19(7):1926–1934.PubMedGoogle Scholar
  13. 13.
    Hennessy SC. Developing standard concentrations in the neonatal intensive care unit. Am J Health Syst Pharm. 2007;64(1):28–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–270.PubMedCrossRefGoogle Scholar
  15. 15.
    Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163(17):2014–2018.PubMedCrossRefGoogle Scholar
  16. 16.
    Wang JK, Herzog NS, Kaushal R, Park C, Mochizuki C, Weingarten SR. Prevention of pediatric medication errors by hospital pharmacists and the potential benefit of computerized physician order entry. Pediatrics. 2007;119(1):e77–e85.PubMedCrossRefGoogle Scholar
  17. 17.
    Veltri MA, Ascenzi J, Clark JS, et al. Successful Elimination of the “Rule of Six” in an Academic Children's Hospital Through a Medication-Use-System Redesign and Standardization of Continuous Infusions. American Society of Health-Systems Pharmacists 2006 Mid Year Meeting [Poster]; 2006. Available at: bestpractices/2006_papers/veltri.htm. Accessed December 21, 2008.
  18. 18.
    Lehmann CU, Kim GR, Gujral R, Veltri MA, Clark JS, Miller MR. Decreasing errors in pediatric continuous intravenous infusions. Pediatr Crit Care Med. 2006;7(3):225–230.PubMedCrossRefGoogle Scholar
  19. 19.
    Joint Commission. Transition to standardized drug concentrations by the end of 2008. Jt Comm Perspect. 2005;25(4):3–5.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Sandra H. Mitchell
    • 1
  • Michael A. Veltri
    • 2
  • George R. Kim
    1. 1.Department of Medicine and in PediatricsMassachusetts General HospitalBoston
    2. 2.The Johns Hopkins Children's CenterBaltimore

    Personalised recommendations